In this context and despite the lack of a thorough understanding of CD6 function, availability of mouse and humanized anti-CD6 mAbs has provided valuable information regarding the potential targeting of CD6 for the treatment of RA, psoriasis and potentially other T cell–driven autoimmune conditions [119]. This evidence concerns the gene CD6 and Autoimmunity.